Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Mylan launches generic version of Apresoline injection in US
Mylan announced the US launch of Hydralazine Hydrochloride Injection USP, 20 mg/mL, which is a generic version of Novartis' Apresoline Injection, 20 mg/mL.
Allergan Receives FDA Approval to Launch First Generic Version of Crestor
Allergan, a leading global pharmaceutical company, confirmed that it has received final approval from the U.
Mylan taps Sarah Jessica Parker to rep anaphylaxis film contest
May is Food Allergy Action Month, and Mylan is making the most of it.
NICE gives tentative broad approval to both Repatha, Praluent
Sanofi and Regeneron put a list price of about $5,780 on their new-gen cholesterol lowering drug Praluent when they took it to the U.
Soon, a botanical drug to cure dengue!
New Delhi.
High stress triggers Alzheimer risk: Study
New Delhi.
Teva Pharm finalizing asset sales to clear Allergan deal: source
Teva Pharmaceutical Industries Ltd is finalizing as much as $2 billion in asset sale agreements to win U.
Valeant forms internal committee to oversee drug pricing
Valeant Pharmaceuticals International Inc, which has acknowledged mistakes in its drug pricing practices amid U.
US biotech firm gets permission to conduct groundbreaking trial to bring back to life central nervous system of clinically dead patients
Another groundbreaking medical experiment is expected to create buzz and controversy similar to when Italian surgeon Sergio Canavero announced plans to perform the world’s first head transplant on a...
Japanese scientists have used skin cells to restore a patient's vision for the first time
Japanese scientists have reported the first successful skin-to-eye stem cell transplant in humans, where stem cells derived from a patient's skin were transplanted into her eye to partially restor...
Pfizer Needs Clearer Goals
Pfizer’s record with mergers hardly inspires confidence.
EC approves eribulin for the treatment of advanced liposarcoma
The European Commission (EC) has approved a variation to the terms of the Marketing Authorisation (MA) of Eisai’s eribulin for the treatment of adult patients with unresectable lipos...
624
625
626
627
628
629
630
631
632
